Clinical trials
Recruiting Observational Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 13 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 56 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BDH-Klinik Hessisch Oldendorf | 3 |
| Boston Children's Hospital | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Imagine Institute | 2 |
| Istituti Clinici Scientifici Maugeri SpA | 2 |
| National Institute of Mental Health (NIMH) | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Norwegian University of Science and Technology | 2 |
| Alzheimer's Disease and Related Disorders Association, Inc | 1 |
| American Federation of Medical Synergetics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 56 |
| Brain Diseases | 11 |
| Neurodegenerative Diseases | 9 |
| Central Nervous System Diseases | 8 |
| Stroke | 8 |
| Epilepsy | 7 |
| Metabolic Diseases | 6 |
| Alzheimer Disease | 5 |
| Cardiovascular Diseases | 5 |
| Cerebrovascular Disorders | 5 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.